Lissner Östlund E, Levin H, Nielsen N, Frigyesi A, Lybeck A. Neuron-specific enolase and long-term neurological outcome after OHCA-A validation study. Resuscitation. 2021;168:206–13.
Isgrò MA, Bottoni P, Scatena R. Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv Exp Med Biol. 2015;867:125–43.
Meric E, Gunduz A, Turedi S, Cakir E, Yandi M. The prognostic value of neuron-specific enolase in head trauma patients. J Emerg Med. 2010;38:297–301.
Lascarrou JB, Miailhe AF, le Gouge A, Cariou A, Dequin PF, Reignier J, Coupez E, Quenot JP, Legriel S, Pichon N, Thevenin D. NSE as a predictor of death or poor neurological outcome after non-shockable cardiac arrest due to any cause: ancillary study of HYPERION trial data. Resuscitation. 2021;158:193–200.
Müller J, Bissmann B, Becker C, Beck K, Loretz N, Gross S, Amacher SA, Bohren C, Pargger H, Tisljar K, Sutter R. Neuron-specific enolase (NSE) predicts long-term mortality in adult patients after cardiac arrest: results from a prospective trial. Medicines (Basel). 2021;8:72.
Kimura F, Kadohama T, Kitahara H, Ise H, Nakanishi S, Akasaka N, Kamiya H. Serum neuron-specific enolase level as predictor of neurologic outcome after aortic surgery. Thorac Cardiovasc Surg. 2020;68:282–90.
Day IN, Thompson RJ. Levels of immunoreactive aldolase C, creatine kinase-BB, neuronal and non-neuronal enolase, and 14-3-3 protein in circulating human blood cells. Clin Chim Acta. 1984;136:219–28.
Article CAS PubMed Google Scholar
Tolan NV, Vidal-Folch N, Algeciras-Schimnich A, Singh RJ, Grebe SK. Individualized correction of neuron-specific enolase (NSE) measurement in hemolyzed serum samples. Clin Chim Acta. 2013;424:216–21.
Article CAS PubMed Google Scholar
Mastroianni A, Panella R, Morelli D. Invisible hemolysis in serum samples interferes in NSE measurement. Tumori. 2020;106:79–81.
Article CAS PubMed Google Scholar
Safar P. Resuscitation after brain ischemia. Brain Fail Resusc. 1981;155:84.
R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. 2021. https://www.R-project.org/. Accessed 1 Mar 2022.
Schrage B, Rübsamen N, Becher PM, Roedl K, Söffker G, Schwarzl M, Dreher A, Schewel J, Ghanem A, Grahn H, Lubos E. Neuron-specific-enolase as a predictor of the neurologic outcome after cardiopulmonary resuscitation in patients on ECMO. Resuscitation. 2019;136:14–20.
Floerchinger B, Philipp A, Camboni D, Foltan M, Lunz D, Lubnow M, Zausig Y, Schmid C. NSE serum levels in extracorporeal life support patients-relevance for neurological outcome? Resuscitation. 2017;121:166–71.
Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653–62.
Article CAS PubMed Google Scholar
Shih AW, McFarlane A, Verhovsek M. Haptoglobin testing in hemolysis: measurement and interpretation. Am J Hematol. 2014;89:443–7.
Article CAS PubMed Google Scholar
Lim SK, Ferraro B, Moore K, Halliwell B. Role of haptoglobin in free hemoglobin metabolism. Redox Rep. 2001;6:219–27.
Article CAS PubMed Google Scholar
Lyu L, Long C, Hei F, Ji B, Liu J, Yu K, Chen L, Yao J, Hu Q, Hu J, Gao G. Plasma free hemoglobin is a predictor of acute renal failure during adult venous-arterial extracorporeal membrane oxygenation support. J Cardiothorac Vasc Anesth. 2016;30:891–5.
Hokka M, Egi M, Kubota K, Mizobuchi S. Perioperative serum free hemoglobin and haptoglobin levels in valvular and aortic surgery with cardiopulmonary bypass: their associations with postoperative kidney injury. J Cardiothorac Vasc Anesth. 2021;35:3207–14.
Article CAS PubMed Google Scholar
Haque A, Ray SK, Cox A, Banik NL. Neuron specific enolase: a promising therapeutic target in acute spinal cord injury. Metab Brain Dis. 2016;31:487–95.
留言 (0)